Actively Recruiting
Visugromab in Cachexia International Trial
Led by CatalYm GmbH · Updated on 2026-04-23
518
Participants Needed
7
Research Sites
241 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questions it aims to answer are: * Does visugromab help participants put weight back on and have a better appetite? * Does visugromab help participants move more and better? * What medical problems do participants have when taking visugromab? Researchers will compare visugromab to a placebo (a look-alike substance that contains no drug). Participants will visit the hospital or clinic once every 4 weeks to receive visugromab or placebo via a drip into a vein and to undergo checkups and tests.
CONDITIONS
Official Title
Visugromab in Cachexia International Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Weight loss
- Advanced cancer
You will not qualify if you...
- Participation in another interventional clinical trial, receipt of any investigational therapy or use of any investigational device within 4 weeks prior to screening and between screening and the first dose of investigational product
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Mid Florida Hematology and Oncology Centers
Orange City, Florida, United States, 32763
Actively Recruiting
2
Specialized Hospital for Active Treatment in Oncology
Haskovo, Bulgaria, 6300
Actively Recruiting
3
Léon Bérard Center (Centre Léon Bérard)
Lyon, France, 69008
Actively Recruiting
4
Oslo University Hospital
Oslo, Norway, 0372
Actively Recruiting
5
University Hospital of A Coruña (Hospital Universitario de A Coruña)
A Coruña, Spain, 15006
Actively Recruiting
6
Cantonal Hospital St. Gallen (Kantonsspital St. Gallen)
Sankt Gallen, Switzerland, 9000
Actively Recruiting
7
University Hospital of Zurich (Universitätsspital Zürich)
Zurich, Switzerland, 8006
Actively Recruiting
Research Team
T
Trial Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here